New Polyketides With Anti-Inflammatory Activity From the Fungus Aspergillus rugulosa

Qianqian Xu, Yuben Qiao, Zijun Zhang, Yanfang Deng, Tianqi Chen, Tao Li, Qiaoxin Xu, Junjun Liu, Weiguang Sun, Ying Ye, Yuanyuan Lu, Changxing Qi, Yonghui ZhangFrontiers in Pharmacology 2021 · DOI

TL;DR

This study identifies two novel polyketide compounds, asperulosins A and B, from the fungus Aspergillus rugulosa, demonstrating significant anti-inflammatory properties. These compounds, particularly asperulosin A, show promise as potential therapeutic agents by effectively suppressing key inflammatory pathways, including nitric oxide production and the activation of NF-κB.

What Problem Does This Paper Address?

Inflammation is a critical biological process, but its dysregulation is implicated in numerous chronic diseases. While many anti-inflammatory drugs exist, there's a continuous need for novel compounds with improved efficacy and fewer side effects. Natural products, particularly those derived from fungi, have historically been a rich source of bioactive molecules. This paper addresses the challenge of discovering new anti-inflammatory agents by exploring the chemical diversity of the fungus Aspergillus rugulosa, a source not extensively studied for its secondary metabolites with anti-inflammatory potential.

Methods

The researchers employed a multi-faceted approach:

  • Isolation and Structure Elucidation: Standard chromatographic techniques (silica gel column chromatography, Sephadex LH-20, and semi-preparative HPLC) were used to isolate compounds from the fungal extract. Structural characterization was achieved through high-resolution electrospray ionization mass spectrometry (HRESIMS) and comprehensive 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
  • Absolute Configuration Determination: For new compounds, the absolute configurations were determined by comparing experimental Electronic Circular Dichroism (ECD) spectra with calculated ECD spectra using the TDDFT method.
  • Anti-inflammatory Assays:
    • Nitric Oxide (NO) Production: RAW264.7 macrophage cells were stimulated with lipopolysaccharide (LPS) to induce inflammation. The production of NO was measured using the Griess reagent.
  • Cytokine Profiling: The secretion levels of various pro-inflammatory (IL6, TNF-α, IFN-γ, MCP-1, IL12) and anti-inflammatory (IL10) cytokines were assessed using a Cytometric Bead Array (CBA) kit.
  • Gene Expression Analysis: Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to measure the transcription levels of inflammatory markers (IL6, IL1β, TNF-α) and M2 macrophage markers (ARG1, CD206).
  • Protein Expression and Localization: Western blotting was employed to analyze the protein levels of key inflammatory mediators like iNOS, COX-2, and NF-κB p65. Immunofluorescence microscopy was used to visualize the nuclear translocation of NF-κB p65.
  • Molecular Docking: Computational docking studies were performed to predict the binding interactions of compounds 1 and 5 with the NF-κB p65 protein, providing insights into their mechanism of action.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Novel Polyketide Structures: The discovery of asperulosins A and B (compounds 1 and 2) adds to the known chemical diversity of polyketides, with compound 2 featuring a rare five-continuous quaternary carbon atom structure.
  • Potent Anti-inflammatory Activity: Compounds 1 and 5 demonstrated significant inhibition of LPS-induced NO production in macrophages, with IC50 values comparable to or better than the positive control, dexamethasone.
  • Modulation of Cytokine Balance: Both compounds effectively shifted the cytokine profile from pro-inflammatory (IL6, TNF-α, IFN-γ, MCP-1, IL12) towards anti-inflammatory (IL10), indicating a broad impact on the immune response.
  • Inhibition of M1 Macrophage Polarization: The compounds suppressed key M1 macrophage markers at both the transcriptional and protein levels, while simultaneously upregulating M2 macrophage markers, suggesting a role in rebalancing immune cell phenotypes.
  • NF-κB Pathway Inhibition: A crucial finding is the ability of compounds 1 and 5 to inhibit the activation and nuclear translocation of NF-κB, a master regulator of inflammation, and its downstream targets like iNOS and COX-2.
  • Mechanism of Action Insights: Molecular docking suggests that compound 1 has a stronger binding affinity to NF-κB p65 than compound 5, potentially explaining its superior anti-inflammatory effects.

Key Results

  • Isolation: Two new polyketides (asperulosins A and B, 1-2) and one new prenylated small molecule (asperulosin C, 3) were isolated, along with nine known compounds (4-12).
  • NO Inhibition: Compound 1 showed an IC50 of 1.49 ± 0.31 µM, and compound 5 showed an IC50 of 3.41 ± 0.85 µM for NO production inhibition. Other compounds had IC50 values >40 µM.
  • Cytokine Modulation: Compounds 1 and 5 significantly increased IL10 levels and decreased IL6, TNF-α, IFN-γ, MCP-1, and IL12 levels in LPS-stimulated RAW264.7 cells.
  • Gene Expression: Compounds 1 and 5 inhibited the mRNA expression of IL6, IL1β, and TNF-α, while increasing IL10, ARG1, and CD206 mRNA.
  • Protein Expression: Compounds 1 and 5 inhibited iNOS and COX-2 mRNA and protein expression. Compound 1 showed more potent inhibition of TLR4, iNOS, and NF-κB p65 protein expression compared to compound 5.
  • NF-κB Translocation: Immunofluorescence confirmed that compounds 1 and 5 inhibited the nuclear translocation of NF-κB p65.

Limitations and Future Work

  • In Vitro Focus: The study primarily focused on in vitro assays using cell lines. Further in vivo studies are needed to confirm the efficacy and safety of these compounds in animal models.
  • Mechanism Elucidation: While NF-κB inhibition is a key finding, a more comprehensive understanding of the precise molecular targets and downstream signaling cascades affected by these compounds could be explored.
  • Structure-Activity Relationship (SAR): Further SAR studies could be conducted to optimize the anti-inflammatory activity of these compounds and develop more potent analogs.
  • Synthesis: The paper mentions that compound 1 is a unique linear chain compound. Exploring synthetic routes to these compounds could facilitate large-scale production and further derivatization for drug development.
  • Comparative Activity: While the compounds were compared to dexamethasone, a more extensive panel of positive controls and a wider range of inflammatory conditions could provide a more robust comparison.

Summary updated

Abstract

Two new polyketide compounds, asperulosins A and B (<b>1</b>-<b>2</b>), and one new prenylated small molecule, asperulosin C (<b>3</b>), along with nine known compounds (<b>4</b>-<b>12</b>), were isolated and identified from a fungus <i>Aspergillus rugulosa</i>. Their structures were extensively elucidated <i>via</i> HRESIMS, 1D, and 2D NMR analysis. The absolute configurations of the new compounds were determined by the comparison of their electronic circular dichroism (ECD), calculated ECD spectra, and the detailed discussion with those in previous reports. Structurally, compounds <b>1</b> and <b>2</b> belonged to the polyketide family and were from different origins. Compound <b>2</b> was constructed by five continuous quaternary carbon atoms, which occur rarely in natural products. All of the isolates were evaluated for anti-inflammatory activity against the production of nitric oxide (NO) in lipopolysaccharide (LPS)-induced RAW264.7 cells. Among those, compounds <b>1</b> and <b>5</b> showed a significant inhibitory effect on NO production with IC<sub>50</sub> values of 1.49 ± 0.31 and 3.41 ± 0.85 <i>μ</i>M, respectively. Additionally, compounds <b>1</b> and <b>5</b> markedly increased the secretion of anti-inflammatory cytokine IL10 while suppressing the secretion of pro-inflammatory cytokines IL6, TNF-α, IFN-γ, MCP-1, and IL12. Besides, <b>1</b> and <b>5</b> inhibited the transcription level of pro-inflammatory macrophage markers IL6, IL1β, and TNF-α while remarkably elevating the anti-inflammatory factor IL10 and M2 macrophage markers ARG1 and CD206. Moreover, <b>1</b> and <b>5</b> restrained the expression and nuclear translocation of NF-κB, as well as its downstream signaling proteins COX-2 and iNOS. All these results suggest that <b>1</b> and <b>5</b> have potential as anti-inflammatory agents, with better or comparable activities than those of the positive control, dexamethasone.
BibTeX
@inproceedings{xu2021new,
  author = {Qianqian Xu and Yuben Qiao and Zijun Zhang and Yanfang Deng and Tianqi Chen and Tao Li and Qiaoxin Xu and Junjun Liu and Weiguang Sun and Ying Ye and Yuanyuan Lu and Changxing Qi and Yonghui Zhang},
  title = {{New Polyketides With Anti-Inflammatory Activity From the Fungus Aspergillus rugulosa}},
  booktitle = {Frontiers in Pharmacology},
  year = {2021},
  doi = {10.3389/fphar.2021.700573},
}
Figure